Cleveland Clinic’s ex-CEO Cosgrove catches on at Google Cloud

Nicholas Leider | | Health Exec | Management

Former CEO and president of the Cleveland Clinic, Toby Cosgrove, MD, will be an executive advisor to Google Cloud’s healthcare and life sciences team.

Currently an executive advisor to the Cleveland Clinic, Cosgrove will aim to improve patient experience and population health, while reducing costs. The team will look to combine technology in healthcare, including electronic health records, with an engaged medical staff.

“[Cosgrove] is a widely respected thought leader in the healthcare space. Over the course of his career, he has seen firsthand how digitization has improved--and hampered--healthcare," Moore, MD, PhD, vice president of healthcare for Google Cloud. "We're thrilled to have Dr. Cosgrove on board to help us tackle the Quadruple Aim, drawing on his several decades of experience at the forefront of American medicine.

Cosgrove, who reportedly turned down a role in Donald Trump’s cabinet as Secretary of the Department of Veterans Affairs, retired at the end of 2017. He served as an adviser Trump on the Strategic and Policy Forum before it was ended in late 2017

Cosgrove expressed his excitement on Twitter last week:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.